Confluence Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $231K | Sell |
15,385
-1,250
| -8% | -$18.8K | ﹤0.01% | 269 |
|
|
2025
Q1 | $219K | Sell |
16,635
-1,655
| -9% | -$21.8K | ﹤0.01% | 278 |
|
|
2024
Q4 | $289K | Hold |
18,290
| – | – | ﹤0.01% | 273 |
|
|
2024
Q3 | $291K | Buy |
18,290
+60
| +0.3% | +$953 | ﹤0.01% | 277 |
|
|
2024
Q2 | $278K | Sell |
18,230
-420
| -2% | -$6.4K | ﹤0.01% | 274 |
|
|
2024
Q1 | $274K | Sell |
18,650
-25
| -0.1% | -$367 | ﹤0.01% | 278 |
|
|
2023
Q4 | $260K | Hold |
18,675
| – | – | ﹤0.01% | 279 |
|
|
2023
Q3 | $250K | Sell |
18,675
-2,720
| -13% | -$36.4K | ﹤0.01% | 269 |
|
|
2023
Q2 | $270K | Hold |
21,395
| – | – | ﹤0.01% | 274 |
|
|
2023
Q1 | $244K | Hold |
21,395
| – | – | ﹤0.01% | 283 |
|
|
2022
Q4 | $221K | Buy |
21,395
+235
| +1% | +$2.43K | ﹤0.01% | 300 |
|
|
2022
Q3 | $222K | Hold |
21,160
| – | – | ﹤0.01% | 286 |
|
|
2022
Q2 | $234K | Sell |
21,160
-220
| -1% | -$2.43K | ﹤0.01% | 294 |
|
|
2022
Q1 | $238K | Sell |
21,380
-3,210
| -13% | -$35.7K | ﹤0.01% | 297 |
|
|
2021
Q4 | $322K | Sell |
24,590
-1,165
| -5% | -$15.3K | ﹤0.01% | 258 |
|
|
2021
Q3 | $336K | Buy |
25,755
+200
| +0.8% | +$2.61K | ﹤0.01% | 258 |
|
|
2021
Q2 | $376K | Sell |
25,555
-1,130
| -4% | -$16.6K | 0.01% | 249 |
|
|
2021
Q1 | $328K | Buy |
26,685
+310
| +1% | +$3.81K | ﹤0.01% | 258 |
|
|
2020
Q4 | $376K | Sell |
26,375
-580
| -2% | -$8.27K | 0.01% | 250 |
|
|
2020
Q3 | $375K | Sell |
26,955
-425
| -2% | -$5.91K | 0.01% | 245 |
|
|
2020
Q2 | $290K | Buy |
+27,380
| New | +$290K | ﹤0.01% | 259 |
|